Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons-Reference-Cited by-同舟云学术

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons

Published:2009-01 Issue:1 Volume:49 Page:64-74
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Goodrich Raymond P.,Murthy Krishna K.,Doane Suzann K.,Fitzpatrick Christy N.,Morrow La Shayla,Arndt Patricia A.,Reddy Heather L.,Buytaert-Hoefen Kimberley A.,Garratty George

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2008.01940.x/fullpdf

Reference39 articles.

1. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference;Klein;Transfusion,2007

2. The design and development of selective, photoactivated drugs for sterilization of blood products;Goodrich;Drugs of the Future,1997

3. Investigation of photosensitizing dyes for pathogen reduction in red cell suspensions;Wagner;Biotech Distochem,2003

4. Council of Europe Expert Committee in Blood Transfusion Study Group on Pathogen Inactivation of Labile Blood Components. Pathogen inactivation of labile blood products;Transfus Med,2001

5. Viability of red cells prepared with S-303 pathogen inactivation treatment;Rios;Transfusion,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model;Transfusion;2021-03-21

2. Quality assessment of red blood cell suspensions derived from pathogen‐reduced whole blood;Vox Sanguinis;2020-11-22

3. The pathogen‐reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases;Vox Sanguinis;2019-02-19

4. Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage;Transfusion Medicine and Hemotherapy;2019

5. Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology;BLOOD TRANSFUS-ITALY;2017